BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vedvyas C, Winterfield LS, Vleugels RA. Calciphylaxis: a systematic review of existing and emerging therapies. J Am Acad Dermatol 2012;67:e253-60. [PMID: 21821309 DOI: 10.1016/j.jaad.2011.06.009] [Cited by in Crossref: 91] [Cited by in F6Publishing: 63] [Article Influence: 8.3] [Reference Citation Analysis]
Number Citing Articles
1 Hawkes J, Karavan M, Bowen A, Summers E. Nonuraemic calciphylaxis and pancreatic cancer: a previously unreported association. Br J Dermatol 2014;171:1247-8. [DOI: 10.1111/bjd.13081] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
2 Twu O, Mednik S, Scumpia P, Doaty S, Worswick S. Use of Becaplermin for nondiabetic ulcers: pyoderma gangrenosum and calciphylaxis. Dermatol Ther 2016;29:104-8. [PMID: 26556220 DOI: 10.1111/dth.12318] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
3 Căpuşă C, Ştefan G, Stancu S, Lipan M, Tsur LD, Mircescu G. Metabolic acidosis of chronic kidney disease and subclinical cardiovascular disease markers: Friend or foe? Medicine (Baltimore) 2017;96:e8802. [PMID: 29381982 DOI: 10.1097/MD.0000000000008802] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
4 Hepschke JL, Masselos K, Sandbach J, Fraser CL. Seeing the difference—Painless progressive vision loss in a vasculopath. Survey of Ophthalmology 2019;64:123-31. [DOI: 10.1016/j.survophthal.2017.09.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
5 Schnur J, Sinawe H, Yoham AL, Casadesus D. Vascular calcifications and calciphylaxis in a patient on concurrent haemodialysis and Coumadin therapy. BMJ Case Rep 2021;14:e240310. [PMID: 33762282 DOI: 10.1136/bcr-2020-240310] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Fergie B, Valecha N, Miller A. A Case of Nonuremic Calciphylaxis in a Caucasian Woman. Case Rep Dermatol Med. 2017;2017:6831703. [PMID: 28191356 DOI: 10.1155/2017/6831703] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
7 Isoherranen K, Bouchard L, Kluger N. Benefits of intralesional injections of sodium thiosulfate in the treatment of calciphylaxis. Int Wound J 2017;14:955-9. [PMID: 28326673 DOI: 10.1111/iwj.12738] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
8 Molenaar FM, van Reekum FE, Rookmaaker MB, Abrahams AC, van Jaarsveld BC. Extraosseous calcification in end-stage renal disease: from visceral organs to vasculature. Semin Dial 2014;27:477-87. [PMID: 24438042 DOI: 10.1111/sdi.12177] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
9 Masoetsa R, AʼGroof A, Kapoor M, Messenger G, Hussain I. Calciphylaxis: Case Presentation and Review of the Literature. J Wound Ostomy Continence Nurs 2018;45:532-5. [PMID: 30216332 DOI: 10.1097/WON.0000000000000473] [Reference Citation Analysis]
10 Lovgren ML, Matthews AG, Torley D. Painful ulcers. Clin Exp Dermatol 2016;41:109-11. [PMID: 25997839 DOI: 10.1111/ced.12688] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Abdalla AO, Al-Khafaji J, Taha M, Malik S. A Fatal Case of Non-Uremic Calciphylaxis: A Case Report and Literature Review. Am J Case Rep 2018;19:804-7. [PMID: 29983410 DOI: 10.12659/AJCR.909546] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
12 Nigwekar SU. Multidisciplinary approach to calcific uremic arteriolopathy. Curr Opin Nephrol Hypertens 2015;24:531-7. [PMID: 26371529 DOI: 10.1097/MNH.0000000000000175] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 2.2] [Reference Citation Analysis]
13 Yu WY, Bhutani T, Kornik R, Pincus LB, Mauro T, Rosenblum MD, Fox LP. Warfarin-Associated Nonuremic Calciphylaxis. JAMA Dermatol 2017;153:309-14. [PMID: 28099971 DOI: 10.1001/jamadermatol.2016.4821] [Cited by in Crossref: 49] [Cited by in F6Publishing: 30] [Article Influence: 9.8] [Reference Citation Analysis]
14 Mochel MC, Arakaki RY, Wang G, Kroshinsky D, Hoang MP. Cutaneous Calciphylaxis: A Retrospective Histopathologic Evaluation. The American Journal of Dermatopathology 2013;35:582-6. [DOI: 10.1097/dad.0b013e31827c7f5d] [Cited by in Crossref: 65] [Cited by in F6Publishing: 19] [Article Influence: 7.2] [Reference Citation Analysis]
15 Dado DN, Huang B, Foster DV, Nielsen JS, Gurney JM, Morrow BD, Sharma K, Chung KK, Ainsworth CR. Management of calciphylaxis in a burn center: A case series and review of the literature. Burns 2019;45:241-6. [PMID: 30322738 DOI: 10.1016/j.burns.2018.09.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
16 Zaayman M, Silfvast-Kaiser A, Rodriguez E, DeCrescenzo AJ, Menter A. Penile calciphylaxis with extragenital gangrene. Proc (Bayl Univ Med Cent) 2021;34:416-8. [PMID: 33953484 DOI: 10.1080/08998280.2020.1868280] [Reference Citation Analysis]
17 Lacouture ME, Sibaud V, Anadkat MJ, Kaffenberger B, Leventhal J, Guindon K, Abou-Alfa G. Dermatologic Adverse Events Associated with Selective Fibroblast Growth Factor Receptor Inhibitors: Overview, Prevention, and Management Guidelines. Oncologist 2021;26:e316-26. [PMID: 33021006 DOI: 10.1002/onco.13552] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
18 Couri T, Stier M, Mikolajczyk A, Aronsohn A. Calciphylaxis in end-stage liver and renal disease patients before and after transplant. Clin Transplant 2018;32:e13272. [PMID: 29714030 DOI: 10.1111/ctr.13272] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Hayashi M. Calciphylaxis: diagnosis and clinical features. Clin Exp Nephrol 2013;17:498-503. [DOI: 10.1007/s10157-013-0782-z] [Cited by in Crossref: 51] [Cited by in F6Publishing: 32] [Article Influence: 5.7] [Reference Citation Analysis]
20 Foley AM. Calciphylaxis: Overview for the vascular nurse. J Vasc Nurs 2017;35:224-9. [PMID: 29153231 DOI: 10.1016/j.jvn.2017.09.005] [Reference Citation Analysis]
21 Ng KP, Edwards NC, Lip GY, Townend JN, Ferro CJ. Atrial Fibrillation in CKD: Balancing the Risks and Benefits of Anticoagulation. American Journal of Kidney Diseases 2013;62:615-32. [DOI: 10.1053/j.ajkd.2013.02.381] [Cited by in Crossref: 46] [Cited by in F6Publishing: 37] [Article Influence: 5.1] [Reference Citation Analysis]
22 Roquet-Gravy C, Théate I, Lejeune M, Vanhooteghem O. A rapid unfavorable penile calciphylaxis case followed by total penectomy. Clin Case Rep 2021;9. [PMID: 34188918 DOI: 10.1002/ccr3.3789] [Reference Citation Analysis]
23 Dayanand P, Sandhyavenu H, Dayanand S, Martinez J, Rangaswami J. Role of Bisphosphonates in Vascular calcification and Bone Metabolism: A Clinical Summary. Curr Cardiol Rev 2018;14:192-9. [PMID: 29921207 DOI: 10.2174/1573403X14666180619103258] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
24 Brandenburg VM, Sinha S, Specht P, Ketteler M. Calcific uraemic arteriolopathy: a rare disease with a potentially high impact on chronic kidney disease-mineral and bone disorder. Pediatr Nephrol 2014;29:2289-98. [PMID: 24474577 DOI: 10.1007/s00467-013-2746-7] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 3.8] [Reference Citation Analysis]
25 Zillioux JM, Geisenhoff A, Gray M. Management of Penile Calciphylaxis: A Case Study. J Wound Ostomy Continence Nurs 2018;45:536-9. [PMID: 30395130 DOI: 10.1097/WON.0000000000000483] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
26 Gomes F, La Feria P, Costa C, Santos R. Non-Uremic Calciphylaxis: A Rare Diagnosis with Limited Therapeutic Strategies. Eur J Case Rep Intern Med 2018;5:000986. [PMID: 30755998 DOI: 10.12890/2018_000986] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
27 Loidi Pascual L, Valcayo Peñalba A, Oscoz Jaime S, Córdoba Iturriagagoitia A, Rodil Fraile R, Yanguas Bayona JI. [Calciphylaxis. A review of 9 cases]. Med Clin (Barc) 2016;147:157-61. [PMID: 27422736 DOI: 10.1016/j.medcli.2016.05.021] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
28 Morrison M, Merati M, Ramirez J, Cha H, Lafond A. Penile calciphylaxis diagnosed with computed tomography. J Eur Acad Dermatol Venereol 2016;30:352-3. [DOI: 10.1111/jdv.12764] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
29 Ossorio-García L, Jiménez-Gallo D, Arjona-Aguilera C, Linares-Barrios M. Multimodal Treatment of Calciphylaxis With Sodium Thiosulfate, Alprostadil, and Hyperbaric Oxygen Therapy. Actas Dermosifiliogr 2016;107:695-7. [PMID: 27208908 DOI: 10.1016/j.ad.2016.04.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
30 Fernández Cañabate S, Alvarez CL, Ortega Valin L, Estifan Ksabji J. Sodium thiosulfate and pamidronate for treatment of calciphylaxis: case report. Colomb Med (Cali) 2018;49:288-91. [PMID: 30700922 DOI: 10.25100/cm.v49i3.4134] [Reference Citation Analysis]
31 Maung MH, Hugh J. Calciphylaxis of the breast with associated diffuse dermal angiomatosis. Human Pathology: Case Reports 2017;9:5-9. [DOI: 10.1016/j.ehpc.2016.12.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
32 Markova A, Lester J, Wang J, Robinson-Bostom L. Diagnosis of common dermopathies in dialysis patients: a review and update. Semin Dial. 2012;25:408-418. [PMID: 22809004 DOI: 10.1111/j.1525-139x.2012.01109.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 7] [Article Influence: 3.6] [Reference Citation Analysis]
33 Gabel CK, Nguyen ED, Chakrala T, Blum AE, François J, Chand S, Rrapi R, Baker O, Dobry AS, Garza-Mayers AC, Ko LN, Shah R, St John J, Nigwekar SU, Kroshinsky D. Assessment of outcomes of calciphylaxis. J Am Acad Dermatol 2021;85:1057-64. [PMID: 33130181 DOI: 10.1016/j.jaad.2020.10.067] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
34 Crotty R, Nazarian RM, Song PI, Van Cott EM. Heparin, warfarin, or calciphylaxis? Am J Hematol 2014;89:785-6. [DOI: 10.1002/ajh.23679] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
35 Galperin TA, Cronin AJ, Leslie KS. Cutaneous manifestations of ESRD. Clin J Am Soc Nephrol. 2014;9:201-218. [PMID: 24115194 DOI: 10.2215/cjn.05900513] [Cited by in Crossref: 32] [Cited by in F6Publishing: 11] [Article Influence: 3.6] [Reference Citation Analysis]
36 Neild GH, Nayer A, Salman L, Asif A. Calciphylaxis. Clin Kidney J 2013;6:653-4. [PMID: 26120460 DOI: 10.1093/ckj/sft110] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
37 Brown C, Cruz E. Generalized Weakness in a Transplant Patient: A Case Presentation. PM R 2016;8:1011-5. [PMID: 27093899 DOI: 10.1016/j.pmrj.2016.04.001] [Reference Citation Analysis]
38 McMullen ER, Harms PW, Lowe L, Fullen DR, Chan MP. Clinicopathologic Features and Calcium Deposition Patterns in Calciphylaxis: Comparison With Gangrene, Peripheral Artery Disease, Chronic Stasis, and Thrombotic Vasculopathy. Am J Surg Pathol 2019;43:1273-81. [PMID: 31192861 DOI: 10.1097/PAS.0000000000001302] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
39 Huilaja L, Turpeinen M, Tokola H, Kauma H, Tasanen K, Ikäheimo R. Warfarin-induced calciphylaxis in patients with normal renal function. J Clin Pharm Ther 2016;41:449-52. [DOI: 10.1111/jcpt.12411] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
40 Lorriaux A, Chaby G, Dhaille F, Dadban A, Arnault JP, Dhillies AS, Lombart F, Chatelain D, Lok C. Nonuraemic calciphylaxis: response to treatment with pamidronate and negative pressure therapy. Clin Exp Dermatol 2015;40:52-5. [DOI: 10.1111/ced.12505] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
41 Brandenburg VM, Cozzolino M, Mazzaferro S. Calcific Uremic Arteriolopathy: A Call for Action. Seminars in Nephrology 2014;34:641-7. [DOI: 10.1016/j.semnephrol.2014.09.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
42 Biswas A, Walsh NM, Tremaine R. A Case of Nonuremic Calciphylaxis Treated Effectively With Systemic Corticosteroids. J Cutan Med Surg. 2016;20:275-278. [PMID: 26700539 DOI: 10.1177/1203475415624104] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
43 Bonchak JG, Park KK, Vethanayagamony T, Sheikh MM, Winterfield LS. Calciphylaxis: a case series and the role of radiology in diagnosis. Int J Dermatol 2016;55:e275-9. [PMID: 26518613 DOI: 10.1111/ijd.13043] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
44 Ossorio-García L, Jiménez-Gallo D, Arjona-Aguilera C, Linares-Barrios M. Intralesional Sodium Thiosulfate to Treat Calciphylaxis. Actas Dermosifiliogr 2016;107:359-62. [PMID: 26739119 DOI: 10.1016/j.ad.2015.10.013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
45 Nathoo RK, Harb JN, Auerbach J, Guo R, Vincek V, Motaparthi K. Pseudoxanthoma elasticum-like changes in nonuremic calciphylaxis: Case series and brief review of a helpful diagnostic clue. J Cutan Pathol. 2017;44:1064-1069. [PMID: 28869660 DOI: 10.1111/cup.13034] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
46 Oliveira TM, Frazão JM. Calciphylaxis: from the disease to the diseased. J Nephrol 2015;28:531-40. [PMID: 25835730 DOI: 10.1007/s40620-015-0192-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
47 Kabbur G, Miller DD. Calciphylaxis: Diagnostic and Treatment Advances for the Inpatient Dermatologist. Curr Derm Rep 2020;9:244-55. [DOI: 10.1007/s13671-020-00316-z] [Reference Citation Analysis]
48 Tangkham R, Sangmala S, Aiempanakit K, Chiratikarnwong K, Auepemkiate S. Calciphylaxis mimicking ecthyma gangrenosum. IDCases 2019;18:e00594. [PMID: 31360636 DOI: 10.1016/j.idcr.2019.e00594] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
49 Hasegawa H. Clinical Assessment of Warfarin Therapy in Patients with Maintenance Dialysis-Clinical Efficacy, Risks and Development of Calciphylaxis. Ann Vasc Dis 2017;10:ra. [PMID: 29147170 DOI: 10.3400/avd.ra.17-00062] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
50 Bourgeois P, De Haes P. Sodium thiosulfate as a treatment for calciphylaxis: A case series. J Dermatolog Treat 2016;27:520-4. [PMID: 27051974 DOI: 10.3109/09546634.2016.1163316] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
51 Nigwekar SU, Kroshinsky D, Nazarian RM, Goverman J, Malhotra R, Jackson VA, Kamdar MM, Steele DJ, Thadhani RI. Calciphylaxis: risk factors, diagnosis, and treatment. Am J Kidney Dis. 2015;66:133-146. [PMID: 25960299 DOI: 10.1053/j.ajkd.2015.01.034] [Cited by in Crossref: 217] [Cited by in F6Publishing: 142] [Article Influence: 31.0] [Reference Citation Analysis]
52 &NA;. Association News: . Journal of Hospice & Palliative Nursing 2014;16:252-5. [DOI: 10.1097/njh.0000000000000072] [Reference Citation Analysis]
53 Perceau G. [Uraemic and non-uraemic calcific arteriopathy: The need for rapid diagnosis and therapy]. Ann Dermatol Venereol 2015;142:506-12. [PMID: 26253008 DOI: 10.1016/j.annder.2015.06.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
54 Jiménez-gallo D, Ossorio-garcía L, Linares-barrios M. Calcinosis cutis y calcifilaxis. Actas Dermo-Sifiliográficas 2015;106:785-94. [DOI: 10.1016/j.ad.2015.09.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
55 Ning MS, Dahir KM, Castellanos EH, Mcgirt LY. Sodium thiosulfate in the treatment of non-uremic calciphylaxis. J Dermatol 2013;40:649-52. [DOI: 10.1111/1346-8138.12139] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
56 Chiriac A, Grosu OM, Terinte C, Perţea M. Calcific uremic arteriolopathy (calciphylaxis) calls into question the validity of guidelines of diagnosis and treatment. J Dermatolog Treat 2020;31:545-8. [PMID: 31075991 DOI: 10.1080/09546634.2019.1618435] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
57 Nigwekar SU, Sprague SM. We Do Too Many Parathyroidectomies for Calciphylaxis. Semin Dial 2016;29:312-4. [DOI: 10.1111/sdi.12502] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
58 Gomes Torres JH, Neves Ribeiro SC, Carvalho de Souza I, Fernandes de Almeida Hellebrandt MC, Budib LJ, Freitas Filho LG. Penile necrosis and calciphylaxis. Urol Case Rep 2021;39:101770. [PMID: 34285881 DOI: 10.1016/j.eucr.2021.101770] [Reference Citation Analysis]
59 Biesbroeck LK, Shinohara MM. Inpatient Consultative Dermatology. Med Clin North Am 2015;99:1349-64. [PMID: 26476257 DOI: 10.1016/j.mcna.2015.06.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
60 Erdel BL, Juneja R, Evans-Molina C. A case of calciphylaxis in a patient with hypoparathyroidism and normal renal function. Endocr Pract 2014;20:e102-5. [PMID: 24518186 DOI: 10.4158/EP13509.CR] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
61 AlQattan AS, Ghulam WZ, Aldaoud N, Algheryafi L, Aleisa N, Aldulaijan FA. Breast fat necrosis secondary to warfarin-induced calciphylaxis, a rare mimicker of breast cancer: A case report and a review of literature. Breast J 2021;27:258-63. [PMID: 33480097 DOI: 10.1111/tbj.14160] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
62 Georgesen C, Fox LP, Harp J. Retiform purpura: Workup and therapeutic considerations in select conditions. Journal of the American Academy of Dermatology 2020;82:799-816. [DOI: 10.1016/j.jaad.2019.07.113] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
63 Zitt E, König M, Vychytil A, Auinger M, Wallner M, Lingenhel G, Schilcher G, Rudnicki M, Salmhofer H, Lhotta K. Use of sodium thiosulphate in a multi-interventional setting for the treatment of calciphylaxis in dialysis patients. Nephrol Dial Transplant 2013;28:1232-40. [PMID: 23291368 DOI: 10.1093/ndt/gfs548] [Cited by in Crossref: 52] [Cited by in F6Publishing: 38] [Article Influence: 5.8] [Reference Citation Analysis]
64 van de Laak A, Bedgedjian I, Nicolas A, Nardin C, Algros MP, Valmary-Degano S. [A rare and severe cutaneous disorder in patients with end-stage renal disease on hemodialysis]. Ann Pathol 2013;33:130-2. [PMID: 23582842 DOI: 10.1016/j.annpat.2013.02.003] [Reference Citation Analysis]
65 García-Lozano JA, Ocampo-Candiani J, Martínez-Cabriales SA, Garza-Rodríguez V. An Update on Calciphylaxis. Am J Clin Dermatol 2018;19:599-608. [PMID: 29808451 DOI: 10.1007/s40257-018-0361-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
66 Saito T, Mima Y, Sugiyama M, Miyazawa N, Iida A, Kanazawa N, Suzuki T, Shikida Y, Hamada T, Wada Y, Mizobuchi M, Honda H. Multidisciplinary management of calciphylaxis: a series of 5 patients at a single facility. CEN Case Rep 2020;9:122-8. [PMID: 31849003 DOI: 10.1007/s13730-019-00439-8] [Cited by in Crossref: 4] [Article Influence: 1.3] [Reference Citation Analysis]
67 Deng Y, Xie G, Li C, Zhang H, Yang B, Chen X, Mei C, Mao Z. Calcific uremic arteriolopathy ameliorated by hyperbaric oxygen therapy in high-altitude area. Ren Fail 2014;36:1139-41. [PMID: 24828821 DOI: 10.3109/0886022X.2014.917672] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
68 Lloyd WR, Agarwal S, Nigwekar SU, Esmonde-White K, Loder S, Fagan S, Goverman J, Olsen BR, Jumlongras D, Morris MD, Levi B. Raman spectroscopy for label-free identification of calciphylaxis. J Biomed Opt 2015;20:80501. [PMID: 26263412 DOI: 10.1117/1.JBO.20.8.080501] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
69 Yang TY, Wang TY, Chen M, Sun FJ, Chiu AW, Chen YH. Penile Calciphylaxis in a Patient with End-stage Renal Disease: A Case Report and Review of the Literature. Open Med (Wars) 2018;13:158-63. [PMID: 29756051 DOI: 10.1515/med-2018-0025] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
70 Li X, Liu N, Xia X, Zhang S, Bai J, Wang J. The effects of maggot secretions on the inflammatory cytokines in serum of traumatic rats. Afr J Tradit Complement Altern Med 2013;10:151-4. [PMID: 24146516 DOI: 10.4314/ajtcam.v10i4.24] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
71 Huppmann AR, Leiding JW, Hsu AP, Raffeld M, Uzel G, Pittaluga S, Holland SM. Pathologic Findings in NEMO Deficiency: A Surgical and Autopsy Survey. Pediatr Dev Pathol 2015;18:387-400. [PMID: 26230867 DOI: 10.2350/15-05-1631-OA.1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
72 Chinnadurai R, Sinha S, Lowney AC, Miller M. Pain management in patients with end-stage renal disease and calciphylaxis- a survey of clinical practices among physicians. BMC Nephrol 2020;21:403. [PMID: 32948131 DOI: 10.1186/s12882-020-02067-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
73 Blaha T, Nigwekar S, Combs S, Kaw U, Krishnappa V, Raina R. Dermatologic manifestations in end stage renal disease. Hemodial Int 2019;23:3-18. [PMID: 30520561 DOI: 10.1111/hdi.12689] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
74 Róbert L, Kiss N, Medvecz M, Kuroli E, Sárdy M, Hidvégi B. Epidemiology and Treatment of Calcinosis Cutis: 13 Years of Experience. Indian J Dermatol 2020;65:105-11. [PMID: 32180595 DOI: 10.4103/ijd.IJD_527_18] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
75 Spanakis EK, Sellmeyer DE. Nonuremic calciphylaxis precipitated by teriparatide [rhPTH(1-34)] therapy in the setting of chronic warfarin and glucocorticoid treatment. Osteoporos Int 2014;25:1411-4. [PMID: 24292108 DOI: 10.1007/s00198-013-2580-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]